Product Code: A00532
The global digital PCR market was valued at $508.8 million in 2020, and is projected to reach $1,305.3 million by 2030, registering a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is defined as an approach for the detection & quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.
However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.
By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
- The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global digital PCR market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global digital PCR market growth.
Key Market Segments
By BY TECHNOLOGY
- Droplet Digital Pcr
- Chip Based Digital Pcr
- Beaming Digital Pcr
By BY PRODUCT TYPE
- igital Pcr Systems
- Consumables And Reagents
- Software And Services
By BY APPLICATION
- Clinical Diagnostics
- Forensic And Others
- Research
By BY END USER
- Pharmaceuticals And Biotechnology Industries
- Clinical Diagnostic Laboratories
- Universities And Other Organizations
By BY REGION
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Key Market Players
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- STILLA TECHNOLOGIES
- sysmex corporation
- Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: DIGITAL PCR MARKET, BY TECHNOLOGY
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Droplet Digital Pcr
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Chip Based Digital Pcr
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Beaming Digital Pcr
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
CHAPTER 5: DIGITAL PCR MARKET, BY PRODUCT TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Digital Pcr Systems
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Consumables And Reagents
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Software And Services
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
CHAPTER 6: DIGITAL PCR MARKET, BY APPLICATION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Research
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Clinical Diagnostics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Forensic And Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
CHAPTER 7: DIGITAL PCR MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Pharmaceuticals And Biotechnology Industries
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Clinical Diagnostic Laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Universities And Other Organizations
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
CHAPTER 8: DIGITAL PCR MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 Asia-Pacific
- 8.2.1 Key trends and opportunities
- 8.2.2 Asia-Pacific Market size and forecast, by Technology
- 8.2.3 Asia-Pacific Market size and forecast, by Product Type
- 8.2.4 Asia-Pacific Market size and forecast, by Application
- 8.2.5 Asia-Pacific Market size and forecast, by End User
- 8.2.6 Asia-Pacific Market size and forecast, by country
- 8.2.6.1 Japan
- 8.2.6.1.1 Market size and forecast, by Technology
- 8.2.6.1.2 Market size and forecast, by Product Type
- 8.2.6.1.3 Market size and forecast, by Application
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 China
- 8.2.6.2.1 Market size and forecast, by Technology
- 8.2.6.2.2 Market size and forecast, by Product Type
- 8.2.6.2.3 Market size and forecast, by Application
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Australia
- 8.2.6.3.1 Market size and forecast, by Technology
- 8.2.6.3.2 Market size and forecast, by Product Type
- 8.2.6.3.3 Market size and forecast, by Application
- 8.2.6.3.4 Market size and forecast, by End User
- 8.2.6.4 India
- 8.2.6.4.1 Market size and forecast, by Technology
- 8.2.6.4.2 Market size and forecast, by Product Type
- 8.2.6.4.3 Market size and forecast, by Application
- 8.2.6.4.4 Market size and forecast, by End User
- 8.2.6.5 South Korea
- 8.2.6.5.1 Market size and forecast, by Technology
- 8.2.6.5.2 Market size and forecast, by Product Type
- 8.2.6.5.3 Market size and forecast, by Application
- 8.2.6.5.4 Market size and forecast, by End User
- 8.2.6.6 Taiwan, Republic Of China
- 8.2.6.6.1 Market size and forecast, by Technology
- 8.2.6.6.2 Market size and forecast, by Product Type
- 8.2.6.6.3 Market size and forecast, by Application
- 8.2.6.6.4 Market size and forecast, by End User
- 8.2.6.7 Rest of Asia-Pacific
- 8.2.6.7.1 Market size and forecast, by Technology
- 8.2.6.7.2 Market size and forecast, by Product Type
- 8.2.6.7.3 Market size and forecast, by Application
- 8.2.6.7.4 Market size and forecast, by End User
- 8.3 LAMEA
- 8.3.1 Key trends and opportunities
- 8.3.2 LAMEA Market size and forecast, by Technology
- 8.3.3 LAMEA Market size and forecast, by Product Type
- 8.3.4 LAMEA Market size and forecast, by Application
- 8.3.5 LAMEA Market size and forecast, by End User
- 8.3.6 LAMEA Market size and forecast, by country
- 8.3.6.1 Brazil
- 8.3.6.1.1 Market size and forecast, by Technology
- 8.3.6.1.2 Market size and forecast, by Product Type
- 8.3.6.1.3 Market size and forecast, by Application
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 Saudi Arabia
- 8.3.6.2.1 Market size and forecast, by Technology
- 8.3.6.2.2 Market size and forecast, by Product Type
- 8.3.6.2.3 Market size and forecast, by Application
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 South Africa
- 8.3.6.3.1 Market size and forecast, by Technology
- 8.3.6.3.2 Market size and forecast, by Product Type
- 8.3.6.3.3 Market size and forecast, by Application
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Rest of LAMEA
- 8.3.6.4.1 Market size and forecast, by Technology
- 8.3.6.4.2 Market size and forecast, by Product Type
- 8.3.6.4.3 Market size and forecast, by Application
- 8.3.6.4.4 Market size and forecast, by End User
- 8.4 North America
- 8.4.1 Key trends and opportunities
- 8.4.2 North America Market size and forecast, by Technology
- 8.4.3 North America Market size and forecast, by Product Type
- 8.4.4 North America Market size and forecast, by Application
- 8.4.5 North America Market size and forecast, by End User
- 8.4.6 North America Market size and forecast, by country
- 8.4.6.1 U.S.
- 8.4.6.1.1 Market size and forecast, by Technology
- 8.4.6.1.2 Market size and forecast, by Product Type
- 8.4.6.1.3 Market size and forecast, by Application
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 Canada
- 8.4.6.2.1 Market size and forecast, by Technology
- 8.4.6.2.2 Market size and forecast, by Product Type
- 8.4.6.2.3 Market size and forecast, by Application
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 Mexico
- 8.4.6.3.1 Market size and forecast, by Technology
- 8.4.6.3.2 Market size and forecast, by Product Type
- 8.4.6.3.3 Market size and forecast, by Application
- 8.4.6.3.4 Market size and forecast, by End User
- 8.5 Europe
- 8.5.1 Key trends and opportunities
- 8.5.2 Europe Market size and forecast, by Technology
- 8.5.3 Europe Market size and forecast, by Product Type
- 8.5.4 Europe Market size and forecast, by Application
- 8.5.5 Europe Market size and forecast, by End User
- 8.5.6 Europe Market size and forecast, by country
- 8.5.6.1 Germany
- 8.5.6.1.1 Market size and forecast, by Technology
- 8.5.6.1.2 Market size and forecast, by Product Type
- 8.5.6.1.3 Market size and forecast, by Application
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 France
- 8.5.6.2.1 Market size and forecast, by Technology
- 8.5.6.2.2 Market size and forecast, by Product Type
- 8.5.6.2.3 Market size and forecast, by Application
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 United Kingdom
- 8.5.6.3.1 Market size and forecast, by Technology
- 8.5.6.3.2 Market size and forecast, by Product Type
- 8.5.6.3.3 Market size and forecast, by Application
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Italy
- 8.5.6.4.1 Market size and forecast, by Technology
- 8.5.6.4.2 Market size and forecast, by Product Type
- 8.5.6.4.3 Market size and forecast, by Application
- 8.5.6.4.4 Market size and forecast, by End User
- 8.5.6.5 Spain
- 8.5.6.5.1 Market size and forecast, by Technology
- 8.5.6.5.2 Market size and forecast, by Product Type
- 8.5.6.5.3 Market size and forecast, by Application
- 8.5.6.5.4 Market size and forecast, by End User
- 8.5.6.6 Rest of Europe
- 8.5.6.6.1 Market size and forecast, by Technology
- 8.5.6.6.2 Market size and forecast, by Product Type
- 8.5.6.6.3 Market size and forecast, by Application
- 8.5.6.6.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
CHAPTER 10: COMPANY PROFILES
- 10.1 Avance Biosciences
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Bio-Rad Laboratories, Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Fluidigm Corporation
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 jn medsys
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Merck KGAA
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Precigenome LLC
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 QIAGEN N.V
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 STILLA TECHNOLOGIES
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 sysmex corporation
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Thermo Fisher Scientific, Inc.
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments